Targeting anthrax: Durham firm aims to be global biodefense leader with latest deal
A biodefense company which already has an anti-anthrax product and has secured more than $350 million in federal contracts will soon become part of Durham-based Heat Biologics under terms of a deal announced before markets opened Tuesday.
Read More
